LUNG · Pulmonx Corp
United States · RS rating 72 · As of 2026-10-14
| Price | 1.78 USD |
|---|---|
| 1-day change | +1.1% |
| RS rating (overall / 1M / 3M / 12M) | 72 / 31 / 92 / 63 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 31 / 33 / 45 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +26.5% |
| Sales growth Q/Q | +5.1% |
| Distance from 52-week high | +31.5% |
| Market cap (USD) | $54.1M |